Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15662154rdf:typepubmed:Citationlld:pubmed
pubmed-article:15662154lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:15662154pubmed:issue4lld:pubmed
pubmed-article:15662154pubmed:dateCreated2005-1-21lld:pubmed
pubmed-article:15662154pubmed:abstractTextThe atypical antipsychotics have been recognized to induce diabetes mellitus and ketoacidosis in the adult psychiatric population. This report notes the onset of weight gain, diabetes, and apparent ketosis in a prepubertal boy diagnosed with bipolar disorder and treated with olanzapine. The hyperglycemia rapidly normalized after discontinuation of the olanzapine. Within 2 years, the diabetes recurred. In spite of the normalization of blood-glucose levels, urine ketone tests remained positive and were explained by the fact that patients taking valproic acid may have a false-positive urine test for ketones. Regular monitoring of glucose should be considered in children and adolescents who gain weight while treated with atypical antipsychotics.lld:pubmed
pubmed-article:15662154pubmed:languageenglld:pubmed
pubmed-article:15662154pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15662154pubmed:citationSubsetIMlld:pubmed
pubmed-article:15662154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15662154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15662154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15662154pubmed:statusMEDLINElld:pubmed
pubmed-article:15662154pubmed:issn1044-5463lld:pubmed
pubmed-article:15662154pubmed:authorpubmed-author:CookeDavid...lld:pubmed
pubmed-article:15662154pubmed:authorpubmed-author:RiddleMark...lld:pubmed
pubmed-article:15662154pubmed:authorpubmed-author:CourvoisieHel...lld:pubmed
pubmed-article:15662154pubmed:issnTypePrintlld:pubmed
pubmed-article:15662154pubmed:volume14lld:pubmed
pubmed-article:15662154pubmed:ownerNLMlld:pubmed
pubmed-article:15662154pubmed:authorsCompleteYlld:pubmed
pubmed-article:15662154pubmed:pagination612-6lld:pubmed
pubmed-article:15662154pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:meshHeadingpubmed-meshheading:15662154...lld:pubmed
pubmed-article:15662154pubmed:year2004lld:pubmed
pubmed-article:15662154pubmed:articleTitleOlanzapine-induced diabetes in a seven-year-old boy.lld:pubmed
pubmed-article:15662154pubmed:affiliationDivision of Child and Adolescent Psychiatry Division, Department of Psychiatry, Johns Hopkins Medical Institutions, Baltimore, MD 21287-3325, USA. hcourvoi@jhmi.edlld:pubmed
pubmed-article:15662154pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15662154pubmed:publicationTypeCase Reportslld:pubmed